vs

Side-by-side financial comparison of Definitive Healthcare Corp. (DH) and iQSTEL Inc (IQST). Click either name above to swap in a different company.

iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $61.5M, roughly 1.4× Definitive Healthcare Corp.). iQSTEL Inc runs the higher net margin — -3.2% vs -15.1%, a 11.9% gap on every dollar of revenue. On growth, Definitive Healthcare Corp. posted the faster year-over-year revenue change (-1.2% vs -14.9%). iQSTEL Inc produced more free cash flow last quarter ($-1.2M vs $-1.7M). Over the past eight quarters, iQSTEL Inc's revenue compounded faster (28.0% CAGR vs -1.5%).

Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.

iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.

DH vs IQST — Head-to-Head

Bigger by revenue
IQST
IQST
1.4× larger
IQST
$84.2M
$61.5M
DH
Growing faster (revenue YoY)
DH
DH
+13.7% gap
DH
-1.2%
-14.9%
IQST
Higher net margin
IQST
IQST
11.9% more per $
IQST
-3.2%
-15.1%
DH
More free cash flow
IQST
IQST
$475.8K more FCF
IQST
$-1.2M
$-1.7M
DH
Faster 2-yr revenue CAGR
IQST
IQST
Annualised
IQST
28.0%
-1.5%
DH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DH
DH
IQST
IQST
Revenue
$61.5M
$84.2M
Net Profit
$-9.3M
$-2.7M
Gross Margin
76.2%
3.5%
Operating Margin
-43.3%
-2.9%
Net Margin
-15.1%
-3.2%
Revenue YoY
-1.2%
-14.9%
Net Profit YoY
84.2%
-44.5%
EPS (diluted)
$-0.14
$-0.92

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DH
DH
IQST
IQST
Q4 25
$61.5M
$84.2M
Q3 25
$60.0M
$102.9M
Q2 25
$60.8M
$72.2M
Q1 25
$59.2M
$57.6M
Q4 24
$62.3M
$98.9M
Q3 24
$62.7M
$54.2M
Q2 24
$63.7M
$78.6M
Q1 24
$63.5M
$51.4M
Net Profit
DH
DH
IQST
IQST
Q4 25
$-9.3M
$-2.7M
Q3 25
$-14.8M
$-2.3M
Q2 25
$-7.6M
$-2.3M
Q1 25
$-107.2M
$-1.1M
Q4 24
$-59.1M
$-1.9M
Q3 24
$-130.9M
$-773.0K
Q2 24
$-213.6M
$-2.0M
Q1 24
$-9.5M
$-580.2K
Gross Margin
DH
DH
IQST
IQST
Q4 25
76.2%
3.5%
Q3 25
76.6%
2.7%
Q2 25
76.7%
2.6%
Q1 25
73.9%
3.4%
Q4 24
76.4%
2.7%
Q3 24
78.2%
3.7%
Q2 24
79.2%
2.8%
Q1 24
79.4%
2.7%
Operating Margin
DH
DH
IQST
IQST
Q4 25
-43.3%
-2.9%
Q3 25
-14.5%
-0.5%
Q2 25
-6.9%
-0.9%
Q1 25
-312.2%
-1.0%
Q4 24
-159.8%
-0.3%
Q3 24
-359.5%
-0.1%
Q2 24
-579.9%
-0.4%
Q1 24
-25.6%
-0.4%
Net Margin
DH
DH
IQST
IQST
Q4 25
-15.1%
-3.2%
Q3 25
-24.7%
-2.3%
Q2 25
-12.4%
-3.3%
Q1 25
-181.2%
-2.0%
Q4 24
-94.8%
-1.9%
Q3 24
-208.8%
-1.4%
Q2 24
-335.2%
-2.5%
Q1 24
-15.0%
-1.1%
EPS (diluted)
DH
DH
IQST
IQST
Q4 25
$-0.14
$-0.92
Q3 25
$-0.14
$-0.68
Q2 25
$-0.07
$-0.82
Q1 25
$-0.95
$-0.44
Q4 24
$-0.53
$-1.19
Q3 24
$-1.12
$-0.40
Q2 24
$-1.81
$-0.90
Q1 24
$-0.08
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DH
DH
IQST
IQST
Cash + ST InvestmentsLiquidity on hand
$180.9M
$2.2M
Total DebtLower is stronger
$156.1M
$4.1M
Stockholders' EquityBook value
$379.0M
$16.3M
Total Assets
$735.5M
$51.1M
Debt / EquityLower = less leverage
0.41×
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DH
DH
IQST
IQST
Q4 25
$180.9M
$2.2M
Q3 25
$185.9M
$2.3M
Q2 25
$184.2M
$2.0M
Q1 25
$200.7M
$1.1M
Q4 24
$290.2M
$2.5M
Q3 24
$305.4M
$2.1M
Q2 24
$296.5M
$797.2K
Q1 24
$295.2M
$2.7M
Total Debt
DH
DH
IQST
IQST
Q4 25
$156.1M
$4.1M
Q3 25
$158.2M
$2.7M
Q2 25
$160.3M
$4.5M
Q1 25
$162.4M
$3.5M
Q4 24
$229.4M
$2.5M
Q3 24
$232.7M
$3.2M
Q2 24
$236.0M
$2.5M
Q1 24
$239.3M
$194.0K
Stockholders' Equity
DH
DH
IQST
IQST
Q4 25
$379.0M
$16.3M
Q3 25
$389.7M
$17.9M
Q2 25
$411.2M
$14.3M
Q1 25
$435.9M
$11.6M
Q4 24
$607.2M
$11.9M
Q3 24
$695.6M
$8.1M
Q2 24
$886.3M
$7.6M
Q1 24
$1.2B
$8.4M
Total Assets
DH
DH
IQST
IQST
Q4 25
$735.5M
$51.1M
Q3 25
$755.5M
$46.9M
Q2 25
$770.1M
$51.4M
Q1 25
$808.7M
$42.0M
Q4 24
$1.1B
$79.0M
Q3 24
$1.2B
$32.4M
Q2 24
$1.4B
$30.0M
Q1 24
$1.8B
$22.1M
Debt / Equity
DH
DH
IQST
IQST
Q4 25
0.41×
0.25×
Q3 25
0.41×
0.15×
Q2 25
0.39×
0.31×
Q1 25
0.37×
0.31×
Q4 24
0.38×
0.21×
Q3 24
0.33×
0.40×
Q2 24
0.27×
0.34×
Q1 24
0.20×
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DH
DH
IQST
IQST
Operating Cash FlowLast quarter
$2.7M
$-1.2M
Free Cash FlowOCF − Capex
$-1.7M
$-1.2M
FCF MarginFCF / Revenue
-2.8%
-1.5%
Capex IntensityCapex / Revenue
7.2%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$37.1M
$-4.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DH
DH
IQST
IQST
Q4 25
$2.7M
$-1.2M
Q3 25
$15.7M
$-953.0K
Q2 25
$9.3M
$257.7K
Q1 25
$26.1M
$-1.9M
Q4 24
$8.1M
$-403.7K
Q3 24
$19.4M
$625.0K
Q2 24
$14.0M
$-2.6M
Q1 24
$16.6M
$-536.9K
Free Cash Flow
DH
DH
IQST
IQST
Q4 25
$-1.7M
$-1.2M
Q3 25
$13.4M
$-969.2K
Q2 25
$7.0M
$211.7K
Q1 25
$18.4M
$-2.0M
Q4 24
$-2.8M
$-421.3K
Q3 24
$18.7M
$594.5K
Q2 24
$13.6M
$-2.6M
Q1 24
$16.3M
$-608.5K
FCF Margin
DH
DH
IQST
IQST
Q4 25
-2.8%
-1.5%
Q3 25
22.3%
-0.9%
Q2 25
11.5%
0.3%
Q1 25
31.0%
-3.4%
Q4 24
-4.4%
-0.4%
Q3 24
29.8%
1.1%
Q2 24
21.4%
-3.4%
Q1 24
25.7%
-1.2%
Capex Intensity
DH
DH
IQST
IQST
Q4 25
7.2%
0.0%
Q3 25
3.8%
0.0%
Q2 25
3.8%
0.1%
Q1 25
13.0%
0.1%
Q4 24
17.5%
0.0%
Q3 24
1.2%
0.1%
Q2 24
0.6%
0.0%
Q1 24
0.4%
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DH
DH

Subscription Services$58.5M95%
Professional Services$3.0M5%

IQST
IQST

USA$53.2M63%
Other$29.9M35%
Switzerland$1.1M1%

Related Comparisons